The Food and Drug Administration (FDA) said Monday it authorized a new over-the-counter COVID-19 rapid antigen test that “is expected to double rapid at-home testing capacity in the U.S. over the next several weeks.” The FDA’s emergency use authorization is for the ACON Laboratories Flowflex COVID-19 Home Test, which can be used at home without a prescription. ACON, a San Diego-based…